Bethel Finance: Israeli Stocks: Elbit Imaging, Teva, Flowsense, Delek Group

www.bethelfinance.com
Bethel Finance news:
Israel’s TA-25 Index declined for the first time in four days, retreating 0.2 percent to 1,107.78, at 1:43 p.m. in Tel Aviv. The measure dropped 18 percent last year.

The following stocks rose or fell today. Symbols are in parenthesis.

Elbit Imaging Ltd. (EMIT IT) surged to the highest intraday level since Dec. 15, gaining 8.5 percent to 10.96 shekels. Calcalist reported that the investor in real estate and medical companies is in talks to sell its holdings in U.S. malls to Blackstone Group LP.

Delek Group Ltd. (DLEKG IT) gained the most since Dec. 22 in intraday trading, climbing 2.4 percent to 725 shekels. The holding company was initiated with a “buy” recommendation at UBS AG.

"D. Medical Industries Ltd. (DMED IT) advanced 3.1 percent, the most since Dec. 25, to 5.30 shekels, giving the Tirat Carmel, Israel-based company a market value of 43.3 million shekels ($11 million). The maker of drug-delivery devices said its infusion set was listed in a U.S. diabetes consumer guide" said Peres Sailam from Bethel Finance Ltd.

Flowsense Medical Ltd. (FLSN IT) surged the most since Dec. 25, advancing 9.1 percent to 0.084 shekel. The maker of an automated urine-monitor system signed a memorandum of understanding with a U.S. distributor for the marketing of its URINFO 2000 system.

Teva Pharmaceutical Industries Ltd. (TEVA IT) rose to the highest intraday level since July 14, advancing 3.2 percent to 165.90 shekels, or the equivalent of $43.15. The shares of the world’s largest generic drugmaker advanced on reports Ranbaxy Laboratories Ltd. gained Lipitor market share and as analysts applauded the company’s choice of chief executive officer.